Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 437

Showing 26-50 of 437 citing articles:

Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
Cheng-Han Lee, Yun Fu, Shih‐Jyun Yang, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2769-2769
Open Access | Times Cited: 107
Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, et al.
Metabolites (2020) Vol. 11, Iss. 1, pp. 22-22
Open Access | Times Cited: 102
The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, et al.
Metabolism (2020) Vol. 115, pp. 154455-154455
Open Access | Times Cited: 97
Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Feng‐Bin Lu, Kenneth I. Zheng, Rafael S. Rios, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 12, pp. 2041-2050
Open Access | Times Cited: 94
A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease
Jonathan Zhi Kai Toh, Xin‐Hui Pan, Phoebe Wen Lin Tay, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 11, pp. 2462-2473.e10
Closed Access | Times Cited: 91
Estrogen-Related Receptor Alpha: An Under-Appreciated Potential Target for the Treatment of Metabolic Diseases
Madhulika Tripathi, Paul M. Yen, Brijesh Kumar Singh
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1645-1645
Open Access | Times Cited: 75
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 66
Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Cong Yin, Zihan Li, Yulin Xiang, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 65
Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study
Xiaomo Wang, Shouling Wu, Xiaojie Yuan, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 2, pp. e745-e755
Open Access | Times Cited: 65
Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link?
Gong Feng, Christopher D. Byrne, Giovanni Targher, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1496-1502
Open Access | Times Cited: 59
Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study
Karl Björkström, Linnea Widman, Hannes Hagström
Liver International (2022) Vol. 42, Iss. 4, pp. 820-828
Open Access | Times Cited: 53
Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
Anna Martin, Sonja Lang, Tobias Goeser, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 533-546
Open Access | Times Cited: 46
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
Richeek Pradhan, Hui Yin, Oriana Hoi Yun Yu, et al.
Diabetes Care (2022) Vol. 45, Iss. 4, pp. 819-829
Open Access | Times Cited: 40
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies
Francesco Bellinato, Paolo Gisondi, Alessandro Mantovani, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 7, pp. 1277-1288
Open Access | Times Cited: 40
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 638-650
Closed Access | Times Cited: 40
Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease
Mohamed I. Elsaid, You Li, John F. P. Bridges, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235003-e2235003
Open Access | Times Cited: 37
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
Stergios A. Pοlyzos, Ilias D. Vachliotis, Christos S. Mantzoros
Metabolism (2023) Vol. 147, pp. 155676-155676
Closed Access | Times Cited: 33
Management of metabolic-associated fatty liver disease: The diabetology perspective
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 126-143
Open Access | Times Cited: 32
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
Cristina Bică, Roxana Adriana Stoica, Teodor Salmen, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1136-1136
Open Access | Times Cited: 28
Gastrointestinal cancers in lean individuals with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Matheus Souza, Ivanna Diaz, Ilaria Barchetta, et al.
Liver International (2023) Vol. 44, Iss. 1, pp. 6-14
Open Access | Times Cited: 27
Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution
Arianna Dolce, Sara Della Torre
Nutrients (2023) Vol. 15, Iss. 10, pp. 2335-2335
Open Access | Times Cited: 26
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 24
New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk
Chenan Liu, Tong Liu, Qingsong Zhang, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2335511-e2335511
Open Access | Times Cited: 24
Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials
Yunpeng Gu, Lei Sun, Wei Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro
Fulin Nian, Zhu Chen, Nuyun Jin, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 669, pp. 134-142
Closed Access | Times Cited: 21

Scroll to top